Explore the Value of Adding Induction Chemotherapy to Concurrent Chemoradiotherapy in T3-4N0M0 Nasopharyngeal Carcinoma Patients: A Retrospective Study [Corrigendum]

This article refers to:

Explore the Value of Adding Induction Chemotherapy to Concurrent Chemoradiotherapy in T3-4N0M0 Nasopharyngeal Carcinoma Patients: A Retrospective Study

Li P, Zhang Q, Luo D, et al. Cancer Manag Res. 2021;13:7067–7076.

The authors have advised the affiliation list on page 7067 is incorrect. The correct author list and affiliations are as follows.

Peijing Li^1,2,*Qun Zhang^3,*Donghua Luo^4–6Feng Jiang²Qifeng Jin²Yonghong Hua²Ting Jin²Xiaozhong Chen²

¹Department of Radiotherapy and Oncology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, People’s Republic of China; ²Department of Radiation Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital) and Institute of Cancer and Basic Medicine (IBMC), Chinese Academy of Sciences, Hangzhou, 310000, People’s Republic of China; ³Department of Radiation Oncology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510060, People’s Republic of China; ⁴Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People’s Republic of China; ⁵State Key Laboratory of Oncology in South China, Guangzhou, 510060, People’s Republic of China; ⁶Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, People’s Republic of China